Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2010
11/03/2010CN101875895A Rhodomyrtus tomentosa red wine
11/03/2010CN101875655A Aminobenzoic acid derivative as well as preparation method and application thereof
11/03/2010CN101874881A Chinese medicinal composition and application thereof
11/03/2010CN101874878A Chinese medicinal composition for treating hematemesis and preparation method thereof
11/03/2010CN101874875A Chinese medicinal tea for treating hypertension, hyperlipoidemia and high blood viscosity and preparation method thereof
11/03/2010CN101874852A Quality detecting method of restorex plus extract capsule
11/03/2010CN101874838A Medicament for treating hepatitis B, cirrhosis and hepatic ascites
11/03/2010CN101874827A Chinese medicinal compound preparation used for controlling broiler ascites syndrome
11/03/2010CN101874824A Active extract containing trilobatin and application thereof
11/03/2010CN101874818A Medicament or health-care product composition for reducing blood pressure or blood fat and preparation method and application thereof
11/03/2010CN101874784A Crystal separating drug sustained-release microspherule and preparation method thereof
11/03/2010CN101874533A Golden bamboo tea
11/03/2010CN101407801B Preparation of earthworm fibrinolytic enzyme from Pheretima guillelmi Michaelsen and lyophilized powder preparation for injection prepared thereby
11/03/2010CN101347168B Freezing beverage containing ginger sugar juice and method of preparing the same
11/03/2010CN101264242B Medicaments preparations for treating hemorrhage, pain and dropsy
11/03/2010CN101031288B Medium-chain length fatty alcohols as stimulators of hematopoiesis
11/03/2010CN101002828B Method for preparing Danhong injection, and products thereof
11/02/2010US7825219 Binding protein; therapy for bone tumors
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7824860 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
11/02/2010US7824683 Methods for augmenting an immune response using anti-CD40 antibodies
11/02/2010US7824677 inhibiting blood coagulation mediated by factor X binding to tissue factor; provide superior anti-coagulant activity by binding native human tissue factor with high affinity and specificity; linked covalently to a cell antigen or an effector molecule to provide complement fixing ability
11/02/2010CA2623449C A novel use of bivalirudin in the treatment of acute coronary syndrome
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2311456C Imidazonaphthyridines and their use in inducing cytokine biosynthesis
11/02/2010CA2253246C Purified multimerase
10/2010
10/28/2010WO2010123983A1 Compostions and methods for targeted gene therapy
10/28/2010WO2010123845A2 Siderophore conjugate immunogenic compositions and vaccines
10/28/2010WO2010122504A1 Thiazole derivatives and their use as p2y12 receptor antagonists
10/28/2010WO2010121973A1 Blockers of nmda receptor for the treatment of sickle cell anemia
10/28/2010WO2010078285A3 Pharmaceutical compositions and methods of treating neurological insults
10/28/2010US20100273892 Formulations of tocotrienol quinones for the treatment of ophthalmic diseases
10/28/2010US20100273886 Formulations and methods for lyophilization and lyophilates provided thereby
10/28/2010US20100273872 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
10/28/2010US20100273862 Phosphatases which activate map kinase pathways
10/28/2010US20100273849 Metalloproteinase Inhibitors
10/28/2010US20100273835 Novel compounds
10/28/2010US20100273829 Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273790 Processes for the preparation of rivaroxaban and intermediates thereof
10/28/2010US20100273789 Aminoacyl prodrugs
10/28/2010US20100273766 Substituted oxindol derivatives, medicaments containing said derivatives and use thereof
10/28/2010US20100273765 Rifamycin analogs and uses thereof
10/28/2010US20100273761 Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
10/28/2010US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA
10/28/2010US20100272827 Method for transdermal iontophoretic delivery of chelated agents
10/28/2010US20100272812 Rgd-modified alginate microparticles as a drug release system
10/28/2010US20100272781 Sugar Free Chewable Tablets
10/28/2010US20100272779 Progesterone-containing compositions and devices
10/28/2010US20100272778 Stents having controlled elution
10/28/2010US20100272775 Immobilized biologically active entities having a high degree of biological activity following sterilization
10/28/2010US20100272740 Micro- and nanoscale devices for delivery of active fibronolytic agents
10/28/2010US20100272720 Antibody Fusion Proteins with a Modified FcRn Binding Site
10/28/2010US20100272715 Variable antibodies
10/28/2010US20100272704 Novel patient subgroups for thrombolysis
10/28/2010US20100272685 Porcine Adeno-Associated Viruses
10/28/2010US20100272645 Myocardial perfusion imaging method
10/28/2010CA2756654A1 Thiazole derivatives and their use as p2y12 receptor antagonists
10/27/2010EP2242740A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments
10/27/2010EP2242506A2 Method of treating erythropoietin hyporesponsive anemias
10/27/2010EP2242488A2 Amino acid derivatives used as pharmaceutical substances
10/27/2010EP1355674B1 Oligo alkylene glycol or polyalkylene glycol-coupled thrombin inhibitors
10/27/2010EP1218509B9 Fibroblast growth factor-like polypeptides
10/27/2010EP1112088B1 Method for detecting connective tissue growth factor for diagnosing a renal disorder
10/27/2010CN101874035A Novel sulfated oligosaccharide derivatives
10/27/2010CN101871931A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related therto
10/27/2010CN101870974A Preparation method of proteinase activated receptors agonist and use thereof
10/27/2010CN101870735A Novel high-glycosylation erythropoietin immune fusion protein
10/27/2010CN101870730A Anti-CD-20 monoclonal antibody
10/27/2010CN101870729A Coagulation factor vii polypeptides
10/27/2010CN101869715A Cell particles carrying interfering ribonucleic acid (RNA), preparation method and application thereof
10/27/2010CN101869645A Jinkui kidney qi-replenishing traditional Chinese medicine solid oral preparation and preparation method thereof
10/27/2010CN101869611A Admixture capable of repelling chicken coccidiosis and stopping dysentery and preparation method thereof
10/27/2010CN101869609A Qi-blood tonifying medicament and preparation method and application thereof
10/27/2010CN101376882B Preparation technique and use of ricefield eel fibrin ferment
10/27/2010CN101264238B Preparation of Chinese medicine for treating iron deficiency anemia
10/27/2010CN101239086B Injection drug administration for treating cardio-cerebrovascular disease and preparations thereof
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820722 Comprises a multi-carbon backbone having an at least partially neutralized carboxy or sulfonic functional group and also one or more side chains that have one or more carbon atoms and, optionally, one or more functional groups.
10/26/2010US7820644 Substituted porphyrins
10/26/2010US7820410 Proteins with high immunoreactivity and method for their production
10/26/2010US7820193 Anticancer agents; prevent forming blood vessels; removal blockage
10/26/2010US7820161 Treatment of autoimmune diseases
10/26/2010CA2326501C Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
10/26/2010CA2192928C Benzoheterocyclic derivatives
10/21/2010WO2010121225A2 Method of treating disorders associated with protein kinase ck2 activity
10/21/2010WO2010121122A2 Biomechanical induction of hematopoiesis
10/21/2010WO2010121082A2 Emulsions of perfluorocarbons
10/21/2010WO2010120698A1 Vitamin d receptor agonists and uses thereof
10/21/2010WO2010119877A1 Process for production of amidine derivative
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119306A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
10/21/2010WO2010118968A1 No-donor aspirin derivatives
10/21/2010US20100268329 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
10/21/2010US20100268321 Drug-releasing graft
10/21/2010US20100267842 Emulsions of Perfluorocarbons
10/21/2010US20100267798 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
10/21/2010US20100267768 Process for making modulators of cystic fibrosis transmembrane conductance regulator
10/21/2010US20100267754 Integrin expression inhibitor
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 671